Error: Could not add to watchlist. X

Anthera Pharmaceuticals Inc

+ Watchlist
6TA:GR
Ticker Change
6TA:GR has changed to a new ticker symbol
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Anthera Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis.
ADDRESS
25801 Industrial Boulevard
Suite B
Hayward, CA 94545
United States
PHONE
1-510-856-5600
  • Paul F Truex
    President/CEO/Founder
  • Debra Odink
    Senior VP/CTO
  • Colin Hislop
    Senior VP/Chief Medical Ofcr
  • Klara A Dickinson-Eason
    Senior VP/Chief Regulatory Ofcr
  • May Liu
    Senior VP:Finance & Administration
Show More